Baxter International, the largest maker of IV fluids in the US, said its manufacturing plant in North Carolina, which produces 1.5 million IV fluid bags per day, was damaged by the hurricane.

US hospitals are bracing for a potential shortage of IV fluids after Hurricane Helene closed the country’s biggest manufacturing plant.

The United States launched the most new cancer drugs during the study period (n=345). Other countries with a high number of launches were Japan (n=224), Canada (n=221), Australia (n=204), the United ...

Adding immunotherapy to platinum-gemcitabine chemotherapy can improve outcomes in patients with advanced urothelial carcinoma, but that may depend on the platinum agent used, data suggest.

Treatment with cediranib or cediranib plus olaparib is not superior to standard of care (SOC) in patients with platinum-resistant or -refractory epithelial ovarian cancer, according to results from a ...

(HealthDay News) — Overall survival (OS) after umbilical cord blood transplant (UCBT) has improved over time, according to a study published in Transplantation and Cellular Therapy.

The Healgen at-home test is the first OTC test for influenza detection to be granted marketing authorization outside of an emergency use authorization.

The Dependent Care Expansion of the ACA may have improved survival outcomes among cancer patients aged 19-25 years.

Although young breast cancer survivors who attempted to breastfeed were mostly satisfied with the experience, a majority reported not receiving specific information about breastfeeding after breast ...

In a randomized trial, transperineal and transrectal approaches to prostate biopsies offered similar rates of cancer detection, but transrectal biopsy was associated with a significantly higher ...

Phase 2 data support the feasibility of administering liso-cel in the community setting with outpatient monitoring in appropriate patients.

Data suggest that uptake of colorectal cancer screening increased after the USPSTF issued a recommendation that all average-risk individuals aged 45 to 49 years should undergo screening.